title: Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
abstract: OBJECTIVE
  To compare the ability of normal erythrocytes and erythrocytes from systemic lupus erythematosus (SLE) patients to bind immune complexes (IC), thereby inhibiting IC deposition on polymorphonuclear leukocytes (PMN) and the consequent induction of a PMN respiratory burst (RB).
  
  
  METHODS
  The binding of fluorescein isothiocyanate-labeled IC in 75% autologous serum to whole blood cells or isolated leukocytes from 17 SLE patients and 10 controls was assessed by flow cytometry. Reactive oxygen metabolite (ROM) production by PMN was measured as the intracellular oxidation of dihydrorhodamine 123, on stimulation with unlabeled IC.
  
  
  RESULTS
  Erythrocyte-mediated inhibition of IC uptake by PMN reached a mean +/- SD maximum of 68 +/- 18% in controls and 29 +/- 51% in SLE patients (P < 0.05) and, in the patients, correlated inversely with disease activity. In the presence of erythrocytes from various donors, IC binding to a standard preparation of PMN and their ROM production were inversely proportional to the number of type 1 complement receptors (CR1) per donor erythrocyte. Thus, the ROM production was higher in the presence of SLE patients' erythrocytes (125 +/- 67 CR1/erythrocyte) than with erythrocytes from controls (235 +/- 118 CR1/erythrocyte).
  
  
  CONCLUSIONS
  Erythrocytes from SLE patients are defective in protecting their PMN against IC deposition and induction of the RB.
authors.affiliation: Odense University, Denmark.
authors.forename: C H
authors.initials: CH
authors.lastname: Nielsen
authors.forename: J M
authors.initials: JM
authors.lastname: Rasmussen
authors.forename: A
authors.initials: A
authors.lastname: Voss
authors.forename: P
authors.initials: P
authors.lastname: Junker
authors.forename: R G
authors.initials: RG
authors.lastname: Leslie
mesh_terms: D000293:Adolescent; D000328:Adult; D000936:Antigen-Antibody Complex / Q000276:immunology* / Q000378:metabolism; D002021:Buffers; D004912:Erythrocytes / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D005260:Female; D006098:Granulocytes / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D007962:Leukocytes / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000276:immunology / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D018375:Neutrophil Activation / Q000276:immunology; D009895:Opsonin Proteins / Q000378:metabolism; D010799:Phycoerythrin; D011485:Protein Binding; D011951:Receptors, Complement / Q000097:blood / Q000378:metabolism; D016897:Respiratory Burst / Q000276:immunology
chemical_list: D000936:Antigen-Antibody Complex; D002021:Buffers; D009895:Opsonin Proteins; D011951:Receptors, Complement; D010799:Phycoerythrin